Ketamine Providers in Illinois
45 providers across 21 cities
Illinois has 45 ketamine therapy providers across 21 cities. The most common provider types are ketamine infusion clinic, psychiatry practice, mental health practice. Providers in Illinois commonly treat depression, anxiety, ptsd. Top cities include Chicago, Skokie, Naperville, Bloomingdale, Hoffman Estates.
Ketamine Therapy in Illinois
Illinois offers growing access to ketamine therapy for treatment-resistant depression, chronic pain, and other conditions, with 52 providers listed across the state. From Chicago's established infusion clinics to emerging practices in the suburbs and downstate communities, patients can find both IV ketamine infusions and FDA-approved Spravato treatment. Despite significant mental health provider shortages in central and southern Illinois, the state's ketamine therapy landscape continues to expand.
Illinois ranks 7th nationally with 45 ketamine therapy providers, averaging 2.1 providers per city. The largest provider category is ketamine infusion clinic (42.2% of providers). Chicago leads the state with 15 providers.
State Regulations
Illinois regulates ketamine as a Schedule III controlled substance under both federal DEA rules and state law. Only licensed physicians, advanced practice nurses, and physician assistants with appropriate authority may prescribe or administer it. Chiropractors and homeopathic physicians are explicitly barred from prescribing ketamine. Clinics must maintain DEA registration, proper storage protocols, and detailed documentation.
Insurance & Medicaid Coverage
Illinois Medicaid covers Spravato (esketamine) through managed care plans such as Meridian, but prior authorization is required. Eligibility is limited to adults aged 18-64 with treatment-resistant depression or major depressive disorder with acute suicidal ideation. Patients must have failed adequate trials of oral antidepressants. Initial approval is granted for six months with re-authorization available upon documented clinical response.
Telehealth Options
Illinois follows the DEA's extended telemedicine flexibilities, which allow practitioners to prescribe Schedule III-V controlled substances including ketamine via telehealth without a prior in-person evaluation through December 31, 2026. Providers must use interactive audio-video telecommunications and maintain proper DEA registration.
Cost of Ketamine Therapy
IV ketamine infusions in Illinois typically cost $250–$550 per session. Chicago clinics generally charge $375-$550 per infusion, while suburban and downstate Illinois providers often offer lower rates starting around $250-$350 per session. A standard initial series of 6 infusions runs $1500–$3300. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Illinois has 228 mental health HPSA designations covering approximately 7 million residents. Only 22.93% of the state's mental health care need is met, and an estimated 301 additional practitioners are needed to remove all shortage designations. Southern and central Illinois face the most severe shortages. Illinois has approximately 0.41 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes, ketamine therapy is legal in Illinois when prescribed and administered by licensed physicians or qualified practitioners with DEA registration. It is used off-label for depression since the FDA has not approved ketamine specifically for mental health treatment. Only Spravato (esketamine nasal spray) carries FDA approval for treatment-resistant depression.
- Most insurance carriers in Illinois do not cover IV ketamine infusions because this use is considered off-label. However, Spravato (esketamine) is covered by many major insurance plans including Illinois Medicaid with prior authorization. Some clinics provide superbills so patients can seek partial reimbursement from their insurance providers.
- Under current DEA telemedicine flexibilities extended through December 2026, Illinois providers can prescribe ketamine via telehealth using audio-video consultations. However, IV infusions and Spravato must be administered in certified clinical settings under direct medical supervision, so telehealth is typically limited to consultations and at-home oral ketamine prescriptions.